159 related articles for article (PubMed ID: 25008439)
1. Measuring the severity of topical 5-fluorouracil toxicity.
Korgavkar K; Firoz EF; Xiong M; Lew R; Marcolivio K; Burnside N; Dyer R; Weinstock MA;
J Cutan Med Surg; 2014; 18(4):229-35. PubMed ID: 25008439
[TBL] [Abstract][Full Text] [Related]
2. Localized pemphigus foliaceus induced by topical imiquimod treatment.
Lin R; Ladd DJ; Powell DJ; Way BV
Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
[No Abstract] [Full Text] [Related]
3. Validation of Photograph-Based Toxicity Score for Topical 5-Fluorouracil Cream Application.
Pomerantz H; Korgavkar K; Lee KC; Lew R; Weinstock MA;
J Cutan Med Surg; 2016 Sep; 20(5):458-66. PubMed ID: 27207349
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
[TBL] [Abstract][Full Text] [Related]
5. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
[TBL] [Abstract][Full Text] [Related]
6. Reliability of Clinician Erythema Assessment grading scale.
Tan J; Liu H; Leyden JJ; Leoni MJ
J Am Acad Dermatol; 2014 Oct; 71(4):760-3. PubMed ID: 24999270
[TBL] [Abstract][Full Text] [Related]
7. Bullous variant of acral erythema due to methotrexate.
Kuruvila S; Dalal M; Sivanesan B
Indian J Dermatol Venereol Leprol; 2006; 72(6):440-2. PubMed ID: 17179620
[TBL] [Abstract][Full Text] [Related]
8. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
Adachi A; Nagai H; Horikawa T
Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
[TBL] [Abstract][Full Text] [Related]
9. Acute erythema of the face after methotrexate.
Ham JC; Verhoef CG; van Herpen CM
Neth J Med; 2016 Jan; 74(1):49-50. PubMed ID: 26819365
[No Abstract] [Full Text] [Related]
10. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
Pujol RM; Rocamora V; Lopez-Pousa A; Taberner R; Alomar A
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
[TBL] [Abstract][Full Text] [Related]
11. Subacute cutaneous lupus erythematosus induced by capecitabine.
Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
[No Abstract] [Full Text] [Related]
12. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
Yoshimasu T; Hiroi A; Uede K; Furukawa F
Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
[TBL] [Abstract][Full Text] [Related]
13. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
Gross K; Kircik L; Kricorian G
Dermatol Surg; 2007 Apr; 33(4):433-9; discussion 440. PubMed ID: 17430377
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
Johnson MR; Hageboutros A; Wang K; High L; Smith JB; Diasio RB
Clin Cancer Res; 1999 Aug; 5(8):2006-11. PubMed ID: 10473079
[TBL] [Abstract][Full Text] [Related]
16. Severe necrotising inflammatory skin reaction to topical 5-fluorouracil.
Gokhale NS
Indian J Ophthalmol; 2019 Dec; 67(12):2066-2068. PubMed ID: 31755461
[TBL] [Abstract][Full Text] [Related]
17. Metallic taste as a side effect of topical fluorouracil use.
Han SY; Youker S
J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
Litwin MS; Ryan RF; Ichinose H; Reed RR; Kremetz ET
Proc Natl Cancer Conf; 1972; 7():549-61. PubMed ID: 4764922
[No Abstract] [Full Text] [Related]
19. Cutaneous recall reactions with systemic fluorouracil.
Kirkup ME; Narayan S; Kennedy CT
Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
[TBL] [Abstract][Full Text] [Related]
20. A localized, recurrent pustular eruption following amoxycillin administration.
Shuttleworth D
Clin Exp Dermatol; 1989 Sep; 14(5):367-8. PubMed ID: 2532988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
